Salute e Benessere
Biocomposites invests in InfectoTest GmbH - developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI)
KEELE, England , Oct. 16, 2024 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that it has taken a minority-share interest in InfectoTest GmbH (InfectoTest), a biomedical company based in Berlin that is developing innovative point-of-care systems for the diagnosis of infectious diseases.
One of InfectoTest's lead products in development is InfectoSynovia, a rapid and high-accuracy test that will detect a periprosthetic joint infection (PJI) in less than five minutes.
PJI is a major problem across the world which is growing as the number of joint replacements increases due to ageing populations. In the US alone, the number of hip and knee arthroplasties is expected to quadruple over the next 10 to 20 years. PJI affects more than two percent of these patients and is now the main reason for revision arthroplasty.[i] [ii]
Rapid and accurate diagnosis of PJI is essential to ensuring the patient receives the most appropriate surgical or antimicrobial treatment plan. InfectoSynovia aims to dramatically reduce the diagnosis time to less than five minutes and provide outstanding sensitivity and specificity, using a sample as small as 50 microliters (µl) of synovial fluid.
Thanks to InfectoTest's unique method of electrochemical analysis, which is aided by software that can help give precise interpretation of results, InfectoSynovia will be capable of detecting low grade and culture-negative infections.
Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe , South America , USA , Canada , China and India . Biocomposites is a world leader in the development of innovative calcium compounds and specialty polymers for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry and sports injuries. Biocomposites products are now used in over 1 million procedures per annum and sold in more than 100 countries around the world. Please visit biocomposites.com to learn more.
InfectoTest GmbH is a biomedical company that develops innovative point-of-care diagnostic systems for the diagnosis of infectious diseases. Our mission is to improve the diagnostic process, in order to bring the most appropriate therapy to patients as soon as possible.
[i] https://www.ncbi.nlm.nih.gov/books/NBK448131/
[ii]
https://academic.oup.com/cid/article/77/7/e34/7222985
View original content: https://www.prnewswire.co.uk/news-releases/biocomposites-invests-in-infectotest-gmbh--developers-of-a-bacterial-specific-point-of-care-test-for-periprosthetic-joint-infection-pji-302276776.html